<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Diagnostic Imaging articles</title><description>Diagnostic Imaging articles</description><link>https://www.diagnosticimaging.com/news</link><category>Diagnostic Imaging articles</category><copyright>© 2026 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.</copyright><lastBuildDate>Thu, 18 Jun 2026 20:31:52 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.diagnosticimaging.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Diagnostic Imaging articles</title><width>144</width><height>47</height><link>https://www.diagnosticimaging.com/news</link><url>https://www.diagnosticimaging.com/logo.webp</url></image><item><title>&lt;![CDATA[Can Biomechanical CT Have an Impact in Opportunistic Screening for Osteoporosis?]]&gt;</title><link>https://www.diagnosticimaging.com/view/biomechanical-ct-impact-opportunistic-screening-osteoporosis-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/biomechanical-ct-impact-opportunistic-screening-osteoporosis-</guid><description>&lt;![CDATA[In a recent interview, Mary L. Bouxsein, PhD, discussed challenges with access to dual-energy X-ray absorptiometry (DEXA) screening for osteoporosis, the emergence of biomechanical CT (BCT) and the potential impact of national Medicare coverage of BCT for bone mass measurement.]]&gt;</description><pubDate>Thu, 18 Jun 2026 19:08:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Research Highlights from SNMMI 2026]]&gt;</title><link>https://www.diagnosticimaging.com/view/research-highlights-snmmi-2026</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/research-highlights-snmmi-2026</guid><description>&lt;![CDATA[Catch up on the latest imaging research from the recent SNMMI conference.]]&gt;</description><pubDate>Wed, 17 Jun 2026 18:42:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Can AI Enhance Non-Contrast and Contrast-Enhanced CT Detection of Pancreatic Cancer?]]&gt;</title><link>https://www.diagnosticimaging.com/view/ai-non-contrast-contrast-enhanced-ct-detection-pancreatic-cancer-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/ai-non-contrast-contrast-enhanced-ct-detection-pancreatic-cancer-</guid><description>&lt;![CDATA[For pancreatic cancers less than or equal to 20 mm, a deep learning model offered a nearly 45 percent higher sensitivity rate with non-contrast CT in comparison to unassisted radiologist interpretation.]]&gt;</description><pubDate>Wed, 17 Jun 2026 17:22:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Five Strategies to Facilitate Technology Implementation and Alleviate Radiologist Turnover]]&gt;</title><link>https://www.diagnosticimaging.com/view/five-strategies-technology-implementation-radiologist-turnover</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/five-strategies-technology-implementation-radiologist-turnover</guid><description>&lt;![CDATA[Noting that frustration over slow implementation of technological advances may be contributing to mounting radiologist frustration and subsequent burnout, this author offers key principles for integrating technological solutions into radiology workflows.]]&gt;</description><pubDate>Wed, 17 Jun 2026 10:22:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Molecular Imaging in Focus: Key Takeaways from the 2026 SNMMI Conference with Michael Hofman, MBBS, FRACP]]&gt;</title><link>https://www.diagnosticimaging.com/view/molecular-imaging-in-focus-key-takeaways-2026-snmmi-conference-michael-hofman-mbbs-fracp</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/molecular-imaging-in-focus-key-takeaways-2026-snmmi-conference-michael-hofman-mbbs-fracp</guid><description>&lt;![CDATA[In the latest episode of the Molecular Imaging in Focus series, Michael Hofman, MBBS, FRACP, discussed the potential of an emerging PET radiotracer for DVT detection spotlighted in SNMMI’s “Image of the Year,” a new advance in total body PET/CT and other highlights from the SNMMI conference.]]&gt;</description><pubDate>Wed, 17 Jun 2026 00:25:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Can Breast Ultrasound AI Offer Comparable Sensitivity to Radiologists in Pregnant and Lactating Women?]]&gt;</title><link>https://www.diagnosticimaging.com/view/breast-ultrasound-ai-comparable-sensitivity-radiologists-pregnant-lactating-women-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/breast-ultrasound-ai-comparable-sensitivity-radiologists-pregnant-lactating-women-</guid><description>&lt;![CDATA[While use of an AI software demonstrated significantly higher accuracy in evaluating BI-RADS 2 presentations and no significant difference with radiologists in BI-RADS 4 assessments of breast ultrasound in a sub-analysis, researchers noted the exclusion of galactoceles, fluid collections and skin lesions that are commonly found in pregnant and lactating women.]]&gt;</description><pubDate>Tue, 16 Jun 2026 16:56:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Molecular Imaging in Focus: Heather Jacene, MD, Charts Priorities as the New President of SNMMI ]]&gt;</title><link>https://www.diagnosticimaging.com/view/molecular-imaging-in-focus-heather-jacene-md-charts-priorities-as-new-president-snmmi</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/molecular-imaging-in-focus-heather-jacene-md-charts-priorities-as-new-president-snmmi</guid><description>&lt;![CDATA[In a recent interview, new SNMMI president Heather Jacene, MD, discussed key goals for bolstering workforce development in nuclear medicine, improving infrastructure equity and optimizing emerging advances to facilitate precision treatments in oncology.]]&gt;</description><pubDate>Mon, 15 Jun 2026 19:36:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Radiology Self-Appraisal: Bane or Boon?]]&gt;</title><link>https://www.diagnosticimaging.com/view/radiology-self-appraisal-bane-or-boon-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/radiology-self-appraisal-bane-or-boon-</guid><description>&lt;![CDATA[While perspective is important for reining in an unrelenting perfectionism here and there, the inner drive for achievement can serve as fuel for consistently high quality over the course of a radiologist’s career.]]&gt;</description><pubDate>Mon, 15 Jun 2026 15:10:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[FDA Approves Low-Dose MRI Contrast Agent Gadoquatrane ]]&gt;</title><link>https://www.diagnosticimaging.com/view/fda-approves-low-dose-mri-contrast-agent-gadoquatrane</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/fda-approves-low-dose-mri-contrast-agent-gadoquatrane</guid><description>&lt;![CDATA[Indicated for the detection and visualization of abnormal vascularity in the central nervous system (CNS) and non-CNS body regions, gadoquatrane provides 60 percent less gadolinium dosing in comparison to other macrocyclic gadolinium (Gd)-based contrast agents (mGBCAs).]]&gt;</description><pubDate>Mon, 15 Jun 2026 06:46:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Diagnostic Imaging&apos;s Weekly Scan: June 7 — June 13]]&gt;</title><link>https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-june-7-june-13</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-june-7-june-13</guid><description>&lt;![CDATA[Catch up on the top radiology content of the past week.]]&gt;</description><pubDate>Sat, 13 Jun 2026 15:24:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Addressing Challenges in Radiology Reporting]]&gt;</title><link>https://www.diagnosticimaging.com/view/addressing-challenges-radiology-reporting</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/addressing-challenges-radiology-reporting</guid><description>&lt;![CDATA[In a recent interview, Nina Kottler, MD, discussed the challenges with traditional radiology reporting, its impact on cognitive load and the recently launched AI-enabled platform Mosaic Reporting.]]&gt;</description><pubDate>Fri, 12 Jun 2026 18:46:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[The Hidden Social Price of Remote Work in Radiology]]&gt;</title><link>https://www.diagnosticimaging.com/view/hidden-social-price-of-remote-work-radiology</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/hidden-social-price-of-remote-work-radiology</guid><description>&lt;![CDATA[New research suggests the silent accumulated social costs of remote work are outweighing the benefits of increased flexibility and autonomy.]]&gt;</description><pubDate>Fri, 12 Jun 2026 09:59:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Breast Imaging in Focus: Can GLP-1 Receptor Agonists Reduce Breast Cancer Risk? What New Research Reveals]]&gt;</title><link>https://www.diagnosticimaging.com/view/breast-imaging-in-focus-can-glp-1-receptor-agonists-reduce-breast-cancer-risk-new-research-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/breast-imaging-in-focus-can-glp-1-receptor-agonists-reduce-breast-cancer-risk-new-research-</guid><description>&lt;![CDATA[In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, discusses new research findings from a study involving over 111,000 women that suggest the potential utility of GLP-1 receptor agonists for reducing breast cancer risk.]]&gt;</description><pubDate>Thu, 11 Jun 2026 20:18:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Study: PSMA PET/CT Reduces Biopsy Rate by Nearly 50 Percent for Men with Equivocal or Non-Suspicious Prostate mpMRI]]&gt;</title><link>https://www.diagnosticimaging.com/view/study-psma-pet-ct-reduces-biopsy-rate-nearly-50-percent-men-equivocal-non-suspicious-prostate-mpmri</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/study-psma-pet-ct-reduces-biopsy-rate-nearly-50-percent-men-equivocal-non-suspicious-prostate-mpmri</guid><description>&lt;![CDATA[For men with high clinical risk for prostate cancer (PCa) and a lack of significant findings on mpMRI, triage use of PSMA PET/CT resulted in a 49 percent reduction of biopsies and an 18 percent reduction in detection of clinically insignificant PCa, according to newly published research.]]&gt;</description><pubDate>Thu, 11 Jun 2026 12:48:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[FDA Clears AI-Powered Software for Improving Low-Contrast CT Detection]]&gt;</title><link>https://www.diagnosticimaging.com/view/fda-ai-powered-software-improving-low-contrast-ct-detection</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/fda-ai-powered-software-improving-low-contrast-ct-detection</guid><description>&lt;![CDATA[The AI-enabled image processing with SubtleHD(CT) software reportedly facilitates improved noise reduction and image quality for computed tomography (CT) exams.]]&gt;</description><pubDate>Wed, 10 Jun 2026 16:46:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[DeepHealth Launches AI-Powered Software for Radiology Reporting]]&gt;</title><link>https://www.diagnosticimaging.com/view/deephealth-ai-powered-software-radiology-reporting</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/deephealth-ai-powered-software-radiology-reporting</guid><description>&lt;![CDATA[The Reporting Pro software reportedly offers an array of AI-enabled features that may help streamline radiology reports.]]&gt;</description><pubDate>Wed, 10 Jun 2026 16:43:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Thirteen Takeaways from New Report on AI in Health Care]]&gt;</title><link>https://www.diagnosticimaging.com/view/thirteen-takeaways-new-report-ai-in-health-care</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/thirteen-takeaways-new-report-ai-in-health-care</guid><description>&lt;![CDATA[In a new survey of over 2,000 health-care professionals on AI use, respondents cited benefits ranging from improved work-life balance to preventing medical errors as well as concerns about overreliance on AI and inconsistent or limited training.]]&gt;</description><pubDate>Wed, 10 Jun 2026 11:24:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Should There Be Greater Oversight of MRI Safety?]]&gt;</title><link>https://www.diagnosticimaging.com/view/should-there-be-greater-oversight-of-mri-safety-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/should-there-be-greater-oversight-of-mri-safety-</guid><description>&lt;![CDATA[In recent interviews, Emanuel Kanal, MD, and Tobias Gilk, MRSO, MRSE, noted a lack of point-of-care safety requirements for MRI, a lack of state oversight, and a prevailing lack of minimum standards overall for MRI safety.]]&gt;</description><pubDate>Wed, 10 Jun 2026 09:55:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[The 2026 Medicare Shift in Radiology: What Changes, What to Do]]&gt;</title><link>https://www.diagnosticimaging.com/view/the-2026-medicare-shift-in-radiology-what-changes-what-to-do</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/the-2026-medicare-shift-in-radiology-what-changes-what-to-do</guid><description>&lt;![CDATA[What radiology leaders need to know about the 2026 Medicare Physician Fee Schedule.]]&gt;</description><pubDate>Tue, 09 Jun 2026 20:55:38 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[From Hesitation to Integration: Evidence-Based Adoption of Breast Imaging AI]]&gt;</title><link>https://www.diagnosticimaging.com/view/from-hesitation-to-integration-evidence-based-adoption-of-breast-imaging-ai</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/from-hesitation-to-integration-evidence-based-adoption-of-breast-imaging-ai</guid><description>&lt;![CDATA[David Gruen, MD, MBA, FACR, of Advanced Radiology Consultants, shares how leading programs turned clinical evidence into operational reality.]]&gt;</description><pubDate>Tue, 09 Jun 2026 20:55:32 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[LLMs for Clinical Impact Today in Radiology]]&gt;</title><link>https://www.diagnosticimaging.com/view/llms-for-clinical-impact-today-in-radiology</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/llms-for-clinical-impact-today-in-radiology</guid><description>&lt;![CDATA[What&apos;s already being done with large language models in radiology practice today.]]&gt;</description><pubDate>Tue, 09 Jun 2026 20:55:26 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Can FAPI PET Enhance Pre-Op Evaluation of Peritoneal Carcinomatosis?]]&gt;</title><link>https://www.diagnosticimaging.com/view/fapi-pet-pre-op-evaluation-peritoneal-carcinomatosis-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/fapi-pet-pre-op-evaluation-peritoneal-carcinomatosis-</guid><description>&lt;![CDATA[Preoperative use of (68Ga)Ga-FAPI-46 PET/CT demonstrated an 81 percent intraclass correlation coefficient (ICC) with the intraoperative peritoneal cancer index (PCI) in comparison to 76 percent for MRI and 54 percent for (18F)FDG PET/CT (FDG PET), according to new research presented at the SNMMI conference.]]&gt;</description><pubDate>Tue, 09 Jun 2026 20:05:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Mammography Study: Can AI Detect Potential Breast Cancer Up to a Decade Prior to Diagnosis?]]&gt;</title><link>https://www.diagnosticimaging.com/view/mammography-study-ai-detect-potential-breast-cancer-up-to-a-decade-prior-to-diagnosis-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/mammography-study-ai-detect-potential-breast-cancer-up-to-a-decade-prior-to-diagnosis-</guid><description>&lt;![CDATA[The proportion of breast cancer potentially flagged by three different AI algorithms 10 years prior to diagnosis ranged between 12.7 to 17 percent, according to newly published retrospective research.]]&gt;</description><pubDate>Tue, 09 Jun 2026 16:14:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[What New Phase 3 MRI Findings Reveal About Survodutide in Patients with Obesity and MASLD]]&gt;</title><link>https://www.diagnosticimaging.com/view/new-phase-3-mri-findings-survodutide-obesity-masld</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/new-phase-3-mri-findings-survodutide-obesity-masld</guid><description>&lt;![CDATA[Use of the glucagon receptor/glucagon-like peptide-1 receptor dual agonist survodutide led to a &amp;gt; 30 percent reduction in liver fat content in nearly 85 percent of obese patients with at-risk MASLD, according to MRI findings in new phase 3 research.]]&gt;</description><pubDate>Mon, 08 Jun 2026 17:04:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Radiology: Ready, Aim, FIRE?]]&gt;</title><link>https://www.diagnosticimaging.com/view/radiology-ready-aim-fire-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/radiology-ready-aim-fire-</guid><description>&lt;![CDATA[Are you on the right path to financial independence and retiring early?]]&gt;</description><pubDate>Mon, 08 Jun 2026 10:56:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Radiology Roundup of FDA News: June 1 — June 7]]&gt;</title><link>https://www.diagnosticimaging.com/view/radiology-roundup-fda-news-june-1-june-7</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/radiology-roundup-fda-news-june-1-june-7</guid><description>&lt;![CDATA[Catch up on a variety of new FDA clearances in radiology from the past week.]]&gt;</description><pubDate>Sun, 07 Jun 2026 11:52:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Diagnostic Imaging’s Weekly Scan: May 31 — June 6]]&gt;</title><link>https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-may-31-june-6</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/diagnostic-imaging-weekly-scan-may-31-june-6</guid><description>&lt;![CDATA[Catch up on the top radiology content of the past week.]]&gt;</description><pubDate>Sat, 06 Jun 2026 12:44:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[PSMA PET Plays Key Role in Multinational Phase 3 Trial of Perioperative Apalutamide for PCa]]&gt;</title><link>https://www.diagnosticimaging.com/view/psma-pet-key-role-multinational-phase-3-trial-perioperative-apalutamide-pca</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/psma-pet-key-role-multinational-phase-3-trial-perioperative-apalutamide-pca</guid><description>&lt;![CDATA[While researchers saw no significant difference in metastasis-free survival with the use of perioperative apalutamide in patients undergoing radical prostatectomy based on conventional imaging alone, the addition of PSMA PET imaging revealed a 20 percent higher likelihood of metastasis-free survival with adjunctive apalutamide.]]&gt;</description><pubDate>Sat, 06 Jun 2026 01:01:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[FDA Clears AI Software for Automated Contouring in Radiation Oncology]]&gt;</title><link>https://www.diagnosticimaging.com/view/fda-ai-software-automated-contouring-radiation-oncology</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/fda-ai-software-automated-contouring-radiation-oncology</guid><description>&lt;![CDATA[The MIM Contour ProtegeAI+ 2.0 software reportedly offers new AI-powered contouring models for brain MRIs and pelvic CTs.]]&gt;</description><pubDate>Thu, 04 Jun 2026 23:26:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item><item><title>&lt;![CDATA[Molecular Imaging in Focus: SNMMI: Can a New Total Body PET Scanner Slash Scan Times and Bolster Sensitivity?]]&gt;</title><link>https://www.diagnosticimaging.com/view/snmmi-new-total-body-pet-scanner-slash-scan-times-bolster-sensitivity-</link><guid isPermaLink="true">https://www.diagnosticimaging.com/view/snmmi-new-total-body-pet-scanner-slash-scan-times-bolster-sensitivity-</guid><description>&lt;![CDATA[In comparison to short-axial field of view PET/CT scanners, a total body PET/CT imaging platform with a long axis field of view detected more lesions in 68 percent of patients while reducing scan times by 83 percent, according to new research presented at the SNMMI conference.]]&gt;</description><pubDate>Thu, 04 Jun 2026 20:28:00 GMT</pubDate><media:credit role="publishing company">Diagnostic Imaging</media:credit><category>us</category><source url="https://www.diagnosticimaging.com/rss.xml">Diagnostic Imaging Articles</source></item></channel></rss>